The market size of softgel capsules was worth more than USD 8.9 billion in 2022and will grow at 5.5% CAGR from 2023 to 2032, attributed to the growing occurrence of chronic disorders globally.
Gelatin-based softgel capsules market was valued at over USD 8 billion in 2022, owing to their superior pH-dependent gelling and thermo-reversibility properties.
North America market size for softgel capsules will reach more than USD 3.9 billion by 2032, attributed to the surging healthcare spending in the region.
Major softgel capsules industry players include Procaps Group, Fuji Capsules Co. Ltd., Estrellus, Delpharm Evreux, Captek Softgel International Inc., Patheon, and Guangdong Yichao Biological Co. Ltd., among others.